• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

BioGenex Laboratories Appoints Dr. Jeffrey S. Ross As Medical Director

Posted on: Thursday, 3 March 2005, 21:00 CST

SAN RAMON, Calif., March 3 /PRNewswire/ -- BioGenex Laboratories, Inc., the inventor of Microwave Antigen Retrieval and pioneer of integrated and industrial-scale, high throughput walkaway automation of IHC testing, announced today the appointment of Dr. Jeffrey S. Ross as Medical Director.

In this role, Dr. Ross will serve as a medical and scientific consultant to BioGenex in the areas of on-slide routine and molecular diagnostic testing. Dr. Ross will also conduct collaborative research at his laboratories at the Albany Medical Center for the discovery and development of new biomarkers for patients with cancer and allied diseases.

Dr. Ross is a graduate of Oberlin College, Oberlin, Ohio and The State University of New York at Buffalo School of Medicine in Buffalo, New York. Dr. Ross currently serves as the Senior Scientific Fellow for Oncology for Molecular Medicine at Millennium Pharmaceuticals, Inc., and Chairman of the Department of Pathology and Laboratory Medicine at the Albany Medical College and the Albany Medical Center Hospital. Dr. Ross has received numerous academic awards, three patents in molecular diagnostics and is the author of more than 470 peer-reviewed scientific articles, research abstracts, 3 textbooks and numerous book chapters in the fields of pathology, molecular diagnostics, oncology and translational cancer research.

"I am very pleased to announce Dr. Ross as our new Medical Director," said Krishan Kalra, Ph.D., chairman and CEO, BioGenex. "Dr. Ross is joining us at a very opportune time, and will help us harness the power of genomics to accelerate the pace of discovery in integrated diagnostics, targeted therapies and predictive medicine."

"I am excited to be joining the BioGenex team as Medical Director and have the opportunity to participate in the presentation of the new Xmatrx instrument. I believe the Xmatrx has the potential to dramatically improve the quality, functionality and productivity of automated Immunohistochemistry and In Situ Hybridization," stated Ross.

About BioGenex Laboratories, Inc.

BioGenex, a technology leader in molecular pathology provides systems for complete automation of cell and tissue testing. BioGenex offers a broad range of reagents, detection kits, antibodies, probes, special stains, tissue microarrays, automated staining and imaging systems to streamline and standardize cellular and molecular diagnostics. The automated systems are designed for high throughput at a low cost of ownership, providing ease of use and maximum flexibility for clinical diagnostics, life science research, and drug discovery. For more information on BioGenex Laboratories, visit http://www.biogenex.com/ or call 1-800-421-4149.

BioGenex Laboratories, Inc.

CONTACT: Financial, Dave Winkler, +1-925-543-1312, or Media, DaveSheldon, +1-925-543-1310, or Business Development, Shazi Iqbal,+1-925-866-2533, or Regulatory Affairs, Dr. Philipp Novales-Li,+1-925-866-2579, all of BioGenex Laboratories, Inc.

Web site: http://www.biogenex.com/

Source: PRNewswire

More News in this Category